2024-09-15 - Analysis Report
## Gilead Sciences, Inc. (GILD) Stock Analysis

**Company Overview:** Gilead Sciences, Inc. is a biopharmaceutical company that develops and commercializes treatments for life-threatening diseases. 

**1. Performance vs. S&P 500:**

* **Cumulative Return:** GILD: 20.45%, VOO: 87.74%.
* **Performance Gap:** The performance gap between GILD and VOO is -67.29%, which signifies that GILD has underperformed the S&P 500 significantly. This gap is approximately 22.49% relative to the historical range of performance gaps.

**2. Recent Price Trends:**

* **Closing Price:** 83.16.
* **Moving Averages:** 5-day: 80.69, 20-day: 77.85, 60-day: 73.86.
* **Analysis:** The current price is above all three moving averages, suggesting an upward trend in the short to medium term.

**3. Technical Indicators:**

* **RSI:** 82.64, indicating the stock is in overbought territory.
* **PPO:** 0.39, suggesting bullish momentum.
* **Relative Divergence:** 6.99, indicating a recent short-term upward trend.
* **Expected Return:** 19.64%, representing the potential maximum 5-year return on investment.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-08 | 1.29 | 6.95 B$ |
| 2024-05-08 | -3.34 | 6.69 B$ |
| 2023-11-07 | 1.75 | 7.05 B$ |
| 2023-08-04 | 0.84 | 6.60 B$ |
| 2024-08-08 | 0.84 | 6.60 B$ |

* **Analysis:** The most recent earnings report (2024-08-08) showed an EPS of 1.29, exceeding analysts' expectations of 0.84. Revenue also surpassed estimates at 6.95 B$, indicating a strong financial performance.

**5. Overall Analysis:**

GILD has underperformed the S&P 500 significantly over the long term. However, the stock has recently shown signs of positive momentum, with a rising price, bullish technical indicators, and strong recent earnings exceeding expectations. This suggests a potential for short to medium-term growth.

**6. Considerations:**

* The high RSI reading suggests the stock might be overbought, indicating a potential for a short-term correction.
* While recent earnings were strong, investors should closely monitor future earnings releases and the company's long-term growth strategy.
* GILD's overall performance compared to the broader market remains a concern, and investors should consider this when making investment decisions.

**Disclaimer:** This analysis is for informational purposes only and should not be considered financial advice. Investment decisions should be made based on your own research and consultation with a financial professional. 
